Pacific Biosciences Of California | PACB - Gross Profit On Sales


Pacific Biosciences Of California reported $15.74M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Agilent USD 990M 44M Mar/2026
Bruker USD 379.8M 69.4M Mar/2026
Danaher USD 3.59B 375M Mar/2026
General Electric Aerospace USD 4.24B 439M Mar/2026
Illumina USD 721M 38M Mar/2026
Myriad Genetics USD 146.8M 3M Dec/2025
Pacific Biosciences Of California USD 15.74M 601K Dec/2025
Quidel USD -91.8M 366.6M Mar/2026
Revvity USD 387.66M 34M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Standard Biotools USD 11.31M 74K Mar/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Waters USD 542M 15.42M Mar/2026